Theme: Innovative Cancer Therapy for Tomorrow
Chemotherapy 2017
Conference series LLC, a globally reputed conference organizing body heartily invites participants from all over the world to attend a two day international conference titled “2nd International Conference on Antimicrobial Agents and Chemotherapy” dated October 19-20 at Atlanta, Georgia, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.
Track 1: Antimicrobial Chemotherapy
Antimicrobial chemotherapy is the clinical application of antimicrobial agents to treat infectious disease. Antimicrobial chemotherapy should not be confused with oncological chemotherapy. Paul Ehrlich is commonly considered the founder of antimicrobial chemotherapy.
Related Conferences
8th International Conference on Antimicrobial Agents in Veterinary Medicine, 23–26 August 2016, Budapest, Hungary; World Gynecologic Cancer Conference October 17-18, 2016 Rome, Italy; 2nd World Congress on Prostate Cancer and Therapeutics August 22-23, 2016 Philadelphia, Pennsylvania, USA; 14th World Cancer Convention November 21-23, 2016 Dubai, UAE; Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 2nd Experts Meeting on Gynecologic Oncology March 23-24,2017 Orlando, USA; ICA 2017 :19th International Conference on Antimicrobials, Miami,USA,March 9-10,2017; EMBO|EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany.
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 2: Chemotherapy
Chemotherapy is a category of cancer treatment that uses chemical substances, especially one or more anti-cancer drugs (chemotherapeutic agents) that are given as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent or it may aim to prolong life or to reduce symptoms (palliative chemotherapy). Chemotherapy is one of the major categories of medical oncology (the medical discipline specifically devoted to pharmacotherapy for cancer).
Related Conferences
7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 - December 2, 2016, Munich, Germany; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow, November 9-11, 2016 ,New York; International Conference on Leukemia and Hematologic Oncology October 17-18,2016. Rome, Italy; Exhibition on Surgical Oncology Conferences September 01-03, 2016 Sao Paulo, Brazil.
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 3: Chemotherapy Types
Chemotherapy encompasses a wide variety of therapy treatments. Terms such as "adjuvant," "neoadjuvant," "consolidation," and "palliative" often add to the confusion surrounding chemotherapy if not properly defined and explained. The purpose of this page is to increase the level of understanding about various chemotherapy protocols currently used.
Related Conferences
5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; 7th International Conference Biomarkers & Clinical Research,November 28-30, 2016 Baltimore, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Medical Imaging & Diagnosis May 09-10, 2016 Chicago, USA; International Conference on Nuclear Medicine & Radiation Therapy July 14-15, 2016 Cologne, Germany; Cancer Center Business Summit, February 24 - 25, 2016, Phoenix, USA.
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 4: Chemotherapy Side Effects
Chemotherapeutic techniques have a range of side-effects that depend on the type of medications used. The most common medications affect mainly the fast-dividing cells of the body, such as blood cells and the cells lining the mouth, stomach, and intestines. Chemotherapy-related toxicities can occur acutely after administration, within hours or days, or chronically, from weeks to years.
Related Conferences
International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; The MASCC/ISOO Annual Meeting on Supportive Care in Cancer, June 23 - 25, 2016, Adelaide, Australia; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 - December 2, 2016, Munich, Germany.
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 5: Chemotherapy Protocols
Chemotherapy protocols strive to maximize the elimination of cancer cells while minimizing the negative effects that these protocols have on healthy cells. Much progress in developing successful chemotherapy protocols has been made, including the identification of many different types of cancer and the corresponding development of effective chemotherapy protocol solutions. But there is still much work to be done.
Related Conferences
13th Asia-Pacific Oncologists Annual Meeting October 17-19, 2016 Kuala Lumpur, Malaysia;; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 - December 2, 2016, Munich, Germany; ICACMS 2017 : 19th International Conference on Applications of Chemotherapy and Medical Sciences, October 10-11, 2017, New York, USA
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 6: Nano medicine & Drug Delivery System
Nano medicine is the medical application of nanotechnology. Nano medicine ranges from the medical applications of nanomaterial’s and biological devices, to Nano electronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Limitations to conventional cancer chemotherapy include drug resistance, lack of selectivity, and lack of solubility. Nanoparticles have the potential to overcome these problems.
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery technologies modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance. Drug release is from: diffusion, degradation, swelling, and affinity-based mechanisms.
Related Conferences
International Conference and Exhibition on Nano medicine and Drug Delivery May 29-31, 2017 Osaka, Japan; ICNN 2017 : 19th International Conference on Nanotechnology and Nano medicine, June 21-22, 2017, Vienna, Austria; 6th Annual Drug Delivery & Formulation Americas Summit, June 12-14, 2016, San Diego, CA, US; 9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, Louisiana, USA; 2nd International Conference on Parenteral, December 05-07, 2016 Texas, USA; 3rd World Congress on Pharmacology August 08-10, 2016 Birmingham, UK; Bioavailability and Bioequivalence Summit August 29-31, 2016, USA; Surgical Oncology Conference during September 01-03, 2016, Brazil; Precision Medicine Conference November 03-05, 2016, USA; Translational Medicine Conference November 17-19, 2016, USA; Mesothelioma Summit, November 03-04, 2016, Spain
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 7: Cancer Clinical Trials
Clinical trials are experiments done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. Of every 5,000 cancer molecules identified in the laboratory, about 250 will enter pre-clinical testing. Of this 250, fewer than 10 are tested in clinical trials and on average only one will be approved by regulatory authorities. The process of bringing a new treatment from the research stage (laboratory) to clinic is estimated to take between 10–13 years.
Related Conferences
13th Asia-Pacific Oncologists Annual Meeting October 17-19, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; 2nd International Conference on Clinical Trials August 22-24, 2016 Philadelphia, Pennsylvania, USA; FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials, 23 Jun 2016 - 24 Jun 2016, Boston, United States; Breast Cancer — Inflammatory Breast Cancer and Triple Negative Breast Cancer 2016: Facts, Myths and Novel Discoveries, 05 Aug 2016, Los Angeles, CA, United States.
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 8: Antimicrobial Resistance
Antimicrobial resistance (AMR) is when a microbe evolves to become more or fully resistant to antimicrobials which previously could treat it. This broader term also covers antibiotic resistance, which applies to bacteria and antibiotics. Resistant microbes are increasingly difficult to treat, requiring alternative medications or higher doses—which may be more costly or more toxic. Microbes resistant to multiple antimicrobials are called multidrug resistant (MDR); or sometimes superbugs.
Related Conferences
International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 2nd International Conference and Exhibition on Antibodies and Therapeutics July 11-12, 2016 Philadelphia, Pennsylvania, USA; 5th International Conference on Immunology ,October 24-26, 2016 Chicago, USA; Asthma Events September 14-15, 2016 Amsterdam, Allergy Conferences September 14-15, 2016 Amsterdam, Netherlands; Netherlands; Immunology Conferences October 13-14, 2016, Manchester, UK; Clinical Immunology Conferences, Clinical Immunology Conferences, September 14-15, 2016 Amsterdam, Netherlands.
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 9: Cancer Immunotherapy
Biologic Response Modifiers (BRM), also called immunotherapy, is a type of treatment that mobilizes the body's immune system to fight cancer. The therapy mainly consists of stimulating the immune system to help it do its job more effectively. Tumor Vaccines also work to stimulate the body's immune system.
Related Conferences
Tumor and Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; International Congress on Neuroimmunology & Therapeutics, December 01-03, 2016, USA; The European Academy of Tumor Immunology, November 09-13, 2016, National Harbour, MD; Australasian Society for Immunology, August 21-26, 2016, Melbourne, Australia; British Society for Immunology Congress, December 6 - 9, 2016, Liverpool, UK; Society for Immunotherapy of Cancer, November 09-13, 2016, National Harbour, MD; Annual Immunology meetings, July 21-23, 2016, Germany.
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
Track 10: Antineoplastic Resistance
Antineoplastic resistance, often used interchangeably with chemotherapy resistance, is the multiple drug resistance of neoplastic (cancerous) cells, or the ability of cancer cells to survive and grow despite anti-cancer therapies.
Related Conferences
International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 - December 2, 2016, Munich, Germany; World Gynecologic Cancer Conference October 17-18, 2016 Rome, Italy; International conference on Neuroendocrine Cancer and Radiation Medicine November 7-9, 2016 Las Vegas, USA; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29-December 2, 2016, Munich, Germany; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain;
Recommended Conferences: Cancer Conferences | Cancer Meetings | Cancer Events
ConferenceSeries Ltd invites all the participants from all over the world to attend “2nd International Conference on Antimicrobial Agents and Chemotherapy” a two day international conference on 8thy and 9th of December 2016 at San Antonio, Texas, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.
Chemotherapy 2016 will focus on the latest databases, curation and research done in each and every area of the cancer and its therapy which will help patients to get relief. This conference series will involve burning topics related to Antimicrobial Agents and Chemotherapy mentioned in the conference series tracks and sub tracks. Through this chemotherapy meeting it will offer a unique opportunity for participants, investigators globally to meet, network, and perceive new scientific interactions in transfusion symposiums. Antimicrobial Agents and Chemotherapy2016 will comprise various leading keynote speakers and session speakers who will be delivering their speech on the current research topics of anti-cancer drug development, clinical research on cancer, immunology and vaccines, Chemotherapy Protocols, Advancement in the field of radiopharmaceuticals for treatment of cancer, Treatment of Lymphoma and Leukemias and on novel drug delivery systems for treating cancer. The young researchers and the student participants will gain the opportunity to grab the Best Poster Award by presenting their work as a poster presentation through our Young Researcher Forum in this melanin meeting.
ConferenceSeries Ltd organizes conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publish 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend???
With members from around the world focused on learning about Antimicrobial Agents & Chemotherapy and its advances; this is your best opportunity to reach the largest clambake of participants from the Antimicrobial agents and Chemotherapy community. A life time opportunity to Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Chemotherapy are hallmarks of this conference.
Target Audience:
*) Antimicrobial Agents & Chemotherapy Students, Scientists
*) Antimicrobial Agents & Chemotherapy Researchers
*) Antimicrobial Agents & Chemotherapy Professors from medical colleges
*) Chemotherapy Associations and Societies
*) Business Entrepreneurs
*) Training Institutes
Cancer Breakthrough news that OVARIAN cancer patients could benefit more from new immunotherapy drugs if they are administered straight after chemotherapy has led scientists to research more in the field of Cancer Immunotherapy. Similarly Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). There is the need of new therapy protocol and system to mitigate poor prognosis in chemotherapy resistant lymphoma patients.
According to IMS Health Holdings, the oncology therapeutic market, strengthening with the global spending on drugs, is expected to surpass $150 billion by 2020. The drastic hike is due to the launch of new novel therapies that are directly related to the immune system. Bristol-Myers Squibb Co and Merck along with other companies are putting in their diligent efforts to develop new molecules for the management and treatment of multiple ailments of oncology. Over the last five years, the cost of the oncology drugs rose to 72% in the US, which contributes to $15.9 billion. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2016 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.
Geographically, North America, dominates the market followed by Europe. North America accounted for about 38% share in the overall oncology drugs market in 2016 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.
Why it’s in San Antonio, Texas, USA?
Chemotherapy confers a large burden in the United States. Several evidence-based interventions are available to reduce the incidence, morbidity, and mortality from these cancers. The National Comprehensive Chemotherapy Control Program (NCCCP) is uniquely positioned to implement these interventions in the US population. It is estimated that there will be about 91,000 new cases diagnosed and approximately 28,000 deaths from cancer in the United States during 2016.
Members Associated with Chemotherapy Research
Chemotherapy research associated members in Dallas are about 418, in USA 5684 members and worldwide about 10214 research members.
Hospitals Associated with Chemotherapy Research
Major Chemotherapy associated hospitals in San Antonio are around 2% when compared to worldwide. Hospitals in San Antonio and USA are:
Baylor University Medical Center
UT Southwestern Medical Center
Texas Health Presbyterian Hospital Dallas
Medical City Dallas Hospital
Plaza Medical Center
Texas Health Harris Methodist Hospital Fort Worth
Medical Center of Plano
Parkland Memorial Hospital
Baylor All Saints Medical Center at Fort Worth
Societies Associated with Chemotherapy Research
In world there are about 9,685 societies which are specifically associated with Gynecologic oncology, in which 1289 societies are from USA and the remaining 269 societies are from Dallas.
American Chemotherapy society
National cancer institute
Society of Chemotherapy
International Chemotherapy society
American college of Phlebology
American congress of Chemotherapy
Asian Society of Chemotherapy
Chemotherapy Group
Northern Chemotherapy Centre
Queensland Centre for Chemotherapy
Industries Associated with Chemotherapy Research
Industries associated with Chemotherapy over all worlds are about 85% in which 12% of industries are in USA and in Dallas about 3%.
Johnson & Johnson
Novartis
Roche
Pfizer
Sanofi
Merck
Bristol-myers squibb
Eli Lilly
Celgene
Takeda
AstraZeneca
Merck & Co.
Amgen
Bayer
Otsuka
Pharmacyclics
Incyte
Universities Associated with Chemotherapy Research
Chemotherapy associated universities in world are about 3284, in USA 612 universities.
The University of Texas at Austin
Texas A&M University
Rice University
University of Houston
University of North Texas
Texas Tech University
The University of Texas at Dallas
Baylor University
Southern Methodist University
The University of Texas at Arlington
Texas State University
The University of Texas MD Anderson Cancer Center
The University of Texas at San Antonio
The University of Texas at El Paso
The University of Texas Medical Branch at Galveston
The University of Texas Health Science Center at San Antonio
Baylor College of Medicine
Lamar University
Sam Houston State University
Texas Christian University
University of Texas Southwestern Medical Center
Trinity University
Stephen F. Austin State University
Texas Tech University Health Sciences Center
Texas Woman's University
St. Edward's University
The University of Texas Health Science Center at Houston
Texas A&M University-Corpus Christi
Texas Southern University
Abilene Christian University
Tarleton State University
Texas A&M International University
Angelo State University
Southwestern University
West Texas A&M University
University of Houston-Clear Lake
Texas A&M University-Kingsville
The University of Texas-Pan American
South Texas College of Law
Midwestern State University
Prairie View A&M University
The University of Texas at Brownsville
St. Mary's University
University of Houston-Downtown
University of Dallas
The University of Texas at Tyler
Dallas Baptist University
University of the Incarnate Word
LeTourneau University
Houston Baptist University
University of Mary Hardin-Baylor
Southwestern Adventist University
Our Lady of the Lake University
Texas A&M University-Commerce
Austin College
Texas A&M University at Galveston
Concordia University Texas
The University of Texas of the Permian Basin
Hardin-Simmons University
University of St. Thomas
McMurry University
Sul Ross State University
Texas Wesleyan University
Wayland Baptist University
University of Houston-Victoria
Schreiner University
Lubbock Christian University
Texas A&M University-Texarkana
East Texas Baptist University
Southwestern Assemblies of God University
Huston-Tillotson University
Jarvis Christian College
Wiley College
Texas Lutheran University
Howard Payne University
Amberton University
Paul Quinn College
Dallas Christian College
The University of Texas Health Science Center at Tyler
Texas College
Arlington Baptist College
College of Biblical Studies
Baptist University of the Americas
Market Value on Chemotherapy Research
The global Chemotherapy market in 2010 was valued at $54bn, an increase of 5.1% over the previous year‘s sales of $51.3bn, and is forecasted to grow at a CAGR of 6.9% from 2010–16, reaching $81bn in 2016.
Collectively, the seven major markets (US, 5EU, and Japan) represented 79.1% (or $43bn) of in the Chemotherapy market in 2016. In terms of size, the US dominated the Chemotherapy market, with 2016 sales of $21bn and a market share of 38.5%.
The Chemotherapy market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastic and cytostatic hormonal treatments, dominating this sector. Collectively, the leading 10 brands accounted for almost 58.2% (or $31.4bn) of the Chemotherapy market in 2016.
In 2016 antineoplastic was the leading drug class in the Chemotherapy market. The global antineoplastic market was valued at $46bn in 2016 at a year-on-year (Y-o-Y) growth of 7.3%. The major drugs that contributed to the 2016 sales in the antineoplastic category were Roche‘s Avastin (bevacizumab) at $6.2bn, Herceptin (trastuzumab) at $5.2bn, and MabThera (rituximab) at $5.1bn, with Y-o-Y sales growth of 3.8%, 3.1%, and 3.3% respectively.
The cytostatic hormonal market registered 2016 sales of $8bn at a Y-o-Y decline of 6.5%. AstraZeneca‘s Arimidex (anastrozole) and Novartis‘s Femara (letrozole) led this class, reaching sales of $1.5bn and $1.3bn respectively in 2016.
Market Growth of Chemotherapy Research in the last and upcoming ten years
TechNavio's analysts forecast the Global Chemotherapy market to grow at a CAGR of 12.47% over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of Chemotherapy. The Global Chemotherapy market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market. In next ten years as population ages, the number of people diagnosed with cancer is expected to be double. According to the American Cancer Society, cancer accounts for every 1 of every 4 in U.S deaths, for women it is one in three .The volumes of cancer services continues to grow. Radiation therapy by 3%,infusion therapy by 7% ; Gynecologic services by 10%(annually).With earlier detection, cancer patients will be identified earlier with improvements in chemotherapy, patients will be able to tolerate more treatments, all of which will result in more treatments per patient and more lives saved.
Fund Allotment to Chemotherapy Research
Fund allotted to the individual types of Chemotherapy research in Dollars for Ovarian, Cervical and Uterine cancers 147$, 119$ and 59$ in which Cervical cancer is funded majorly.
Statistics of Physicians, Researchers and Academicians working on Chemotherapy
San Antonio's Biosciences industry employs over 100,000 people. The largest areas of research are conducted by institutes in or around the South Texas Medical Center. These include the Chemotherapy division of one of the world's top five biotechnology firms, the world's largest Phase I clinical trials program for Chemotherapy, and the new $200 million woman’s Cancer Research Institute. Dallas also houses the world's largest genomics computing cluster and the state's public bank for stem cell-rich umbilical cord blood.
Products manufactured by the industry related Chemotherapy Research & their Market Value:
Neosar (Cyclophosphamide) - manufactured by Roxane Laboratories Inc and the market value is17.06$
Paraplat (Carboplatin)-manufactured by Bristol-Myers Squibb Company and the market value is128$
Platinol (Cisplatin)-manufactured by Bristol-Myers Squibb Company and the market value is15.3$
Gemzar (Gemcitabine Hydrochloride)-manufactured by Eli Lilly and Company and the market value is26.1$
Clafen (Cyclophosphamide)-manufactured by Selleckchem and the market value is150$
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | October 19-20, 2017 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
- Journal of Chemotherapy
- Journal of Cancer Science and Therapy
- Journal of Clinical and Experimental Oncology
Abstracts will be provided with Digital Object Identifier by